HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer
Paola Bonaventura, Audrey Page, Olivier Tabone, Yann Estornes, Virginie Mutez, Marie Delles, Sarah Moran, Clarisse Dubois, Thibault Richard, Marjorie Lacourrège, Marie Michelas, Dina M. Tawfik, Ema Etchegaray, Adrian Valente, Rasha E. Boulos, , Stéphane Depil
This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.
Journal for ImmunoTherapy of Cancer · Aug 1, 2025Peer-reviewedImmunology